Early studies suggest that DNMT3A mutations are involved in hematological malignancies such as myelodysplastic syndrome (MDS), adult early T-cell precursor acute lymphoblastic leukemia (ETP-ALL), and AML [13–17]. Here, DNMT3A is linked to myelodysplastic syndrome.